Integrative stemness characteristics associated with prognosis and the immune microenvironment in lung adenocarcinoma

Table 1 Statistics and comparative analysis of clinical information in high and low mRNAsi groups

characteristics total cases	N of case 501	mRNAsi level		P value
characteristics total cases	N of case 501	Low	High	P value
Age(years)
≤ 60	157	86	71	1.493E-01
> 60	344	164	180	1.493E-01
Geneder
Male	231	115	116	9.986E-01
Female	270	135	135	9.986E-01
Pathologic M
M0	333	165	168	6.791E-01
M1	24	13	11	6.791E-01
Pathologic N
N0	324	163	161	7.819E-01
N1	94	46	48
N2	72	39	33
Pathologic T
T1	167	79	88	2.060E-02
T2	267	143	124
T3	45	21	24
T4	19	6	13
Pathologic stage
Stage I	268	148	120	3.337E-03
Stage II	119	62	57
Stage III	81	26	55
Stage IV	25	13	12
Tumor recurrence
Yes	74	77	151	9.309E-01
No	131	144	275	9.309E-01
Radiotherapy
Yes	32	28	60	8.093E-01
No	194	194	388	8.093E-01

ISSN: 1471-2466